Concepedia
Statistics
Publications
1
Citations
32
H-Index
Active since
2008
E Till is an author specializing in solid tumor applications, immunotherapy for solid tumors, and humanized monoclonal antibodies.
Publications per year
2008–2008
A phase I study of AVE1642, a humanized monoclonal antibody IGF-1R (insulin like growth factor1 receptor) antagonist, in patients(pts) with advanced solid tumor(ST)
A. W. Tolcher, A. Patnaik, E Till et al. · Journal of Clinical Oncology · 2008 · 32 citations
Medicine, Oncology, Pharmacology +17
1–1 of 1